# SIRAKI 02 Posthoc Analysis.

> **NCT06781294** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Hospital Universitari de Bellvitge** · enrollment: 343 (actual)

## Conditions studied

- Cardiac Surgery Requiring Cardiopulmonary Bypass
- Acute Kidney Injury
- Chronic Kidney Disease(CKD)
- Kidney Failure, Acute

## Interventions

- **DEVICE:** Extracorporeal Cytokine hemadsorption therapy

## Key facts

- **NCT ID:** NCT06781294
- **Lead sponsor:** Hospital Universitari de Bellvitge
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-10-01
- **Primary completion:** 2026-11-01
- **Final completion:** 2027-03-01
- **Target enrollment:** 343 (ACTUAL)
- **Last updated:** 2026-01-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06781294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06781294, "SIRAKI 02 Posthoc Analysis.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06781294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*